MCM4 is a novel prognostic biomarker and promotes cancer cell growth in glioma

MCM4 is a novel prognostic biomarker and promotes cancer cell growth in glioma

BackgroundGliomas account for 75% of all primary malignant brain tumors in adults and result in high mortality. Accumulated evidence has declared the minichromosome maintenance protein complex (MCM) gene family plays a critical role in modulating the cell cycle and DNA replication stress. However, t...

Full description

Bibliographic Details
Main Authors: Shu Yang, Yixiao Yuan, Wenjun Ren, Haiyu Wang, Zhong Zhao, Heng Zhao, Qizhe Zhao, Xi Chen, Xiulin Jiang, Lei Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Oncology
Subjects:
glioma
MCM family
prognostic model
biomarker
immune infiltration
diagnosis
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.1004324/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.1004324/full

Similar Items